title: Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis.
abstract: Excess red blood cells (RBC) in patients with polycythemia vera (PV) are usually removed by repeated phlebotomy. In order to improve the efficacy of this treatment, we used isovolemic large-volume erythrocytapheresis (EA) by a cell separator. A retrospective analysis of our experience with 69 PV patients (206 EA procedures) is reported. EA induced a rapid, well-tolerated, and long-lasting reduction of Hct, Hb, and RBC counts, as well as an immediate disappearance or reduction of clinical symptoms of PV, while tissue oxygen tension - as measured in 8 patients - increased. Hct was reduced by EA from 56.8% +/- 5.6% to 41.9% +/- 6.6%, Hb from 17.5 +/- 2.3 to 12.7 +/- 2.4 g%, RBC counts from 7.4 +/- 0.9 to 5.4 +/- 0.9 x 10(6)/mm3. The mean volume of the apherisate was 1410 +/- 418 ml, (mean Hct 79.7% +/- 9.3%), and the actual RBC volume removed 1113 +/- 367 ml. The isovolemic procedure was well tolerated and the acceptance by patients seemed to be better than with repeated phlebotomy. In 21 patients whose Hct values (Hct before and after EA 58% +/- 5.7% and 41.5% +/- 4.9%) were regularly followed after EA the mean period with Hct less than 50% after a single EA procedure was 6.1 +/- 4.1 months (median, 6); in 14 out of these 21 patients a Hct of less than 43% after EA was reached and their mean period with Hct less than 50% after EA was 7.6 +/- 4.0 months (median, 7.5). For three patients this period was 11, 13, and 15 months, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Zentrum Innere Medizin, Universität Göttingen.
authors.forename: U
authors.initials: U
authors.lastname: Kaboth
authors.forename: K W
authors.initials: KW
authors.lastname: Rumpf
authors.forename: T
authors.initials: T
authors.lastname: Lipp
authors.forename: J
authors.initials: J
authors.lastname: Bigge
authors.forename: M
authors.initials: M
authors.lastname: Nauck
authors.forename: J H
authors.initials: JH
authors.lastname: Beyer
authors.forename: W
authors.initials: W
authors.lastname: Seyde
authors.forename: W
authors.initials: W
authors.lastname: Kaboth
mesh_terms: D001781:Blood Component Removal; D001815:Bloodletting; D003131:Combined Modality Therapy; D004906:Erythrocyte Count; D017707:Erythrocyte Transfusion; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010865:Pilot Projects; D011087:Polycythemia Vera / Q000097:blood / Q000628:therapy*
chemical_list: D010100:Oxygen